Peregrine Pharma (PPHM) Misses Q1 EPS by 1c

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/6/2026

1. NVDA
2. PCVX
3. PTC
4. MSFT
5. SPY
6. META
7. GOOGL
8. GMAB
9. AMD
10. BBIO

Go back to Peregrine Pharma (PPHM) Misses Q1 EPS by 1c

Roth Remains Neutral on Peregrine Pharma (PPHM); Pipeline Advancing Well, but Catalysts Remain

September 9, 2016 11:09 AM EDT

Roth Capital affirms Peregrine Pharma (Nasdaq: PPHM) with a Neutral rating and $0.50 price target following Q1 results issued Thursday night.

Analyst Joseph Pantginis noted Peregrine's efforts to advances its pipeline. The analyst commented: In our opinion, PPHM is making strategic decisions in order to grow and become profitable through a two pronged approach:... More